Huapont Life Sciences Co., Ltd.

Huapont Life Sciences is a prominent, publicly traded Chinese conglomerate established in 1992 and headquartered in Chongqing. The company operates primarily in the pharmaceutical and agrochemical sectors, with a strong focus on dermatological clinical drugs, tuberculosis treatments, and respiratory medicines, alongside the production of pesticide intermediates and fine chemicals. Beyond its core pharmaceutical and chemical manufacturing, the company maintains a diversified portfolio that includes medical services, new materials, and tourism. It is recognized as a national high-tech enterprise in China, operating multiple API and formulation factories, and has expanded its footprint globally with subsidiaries and operations across Asia, Europe, and the United States.